Correspondence 0001493152-26-022162 from bioAffinity Technologies, Inc. (BIAF)
bioAffinity Technologies, Inc.
Date: May 11, 2026 · CIK: 0001712762 · Accession: 0001493152-26-022162
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295465
Letter
bioAffinity Technologies, Inc.
Nacogdoches Road, Suite 216
San Antonio, Texas 78217
(210) 698-5334
May 11, 2026
VIA EDGAR
United States Securities and Exchange Commission
F Street, N.E.
Washington, D.C. 20549
Attention: Nicholas O'Leary
Re: bioAffinity Technologies, Inc.
Registration Statement on Form S-1
Filed April 30, 2026
File No. 333-295465
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the "Act"), bioAffinity Technologies, Inc. (the "Company") respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Time, on Tuesday, May 12, 2026, or as soon thereafter as possible.
Please notify Sean F. Reid of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 896-0610 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
Very
truly yours,
BIOAFFINITY
TECHNOLOGIES, INC.
Show Raw Text
CORRESP 1 filename1.htm bioAffinity Technologies, Inc. 3300 Nacogdoches Road, Suite 216 San Antonio, Texas 78217 (210) 698-5334 May 11, 2026 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Nicholas O'Leary Re: bioAffinity Technologies, Inc. Registration Statement on Form S-1 Filed April 30, 2026 File No. 333-295465 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the "Act"), bioAffinity Technologies, Inc. (the "Company") respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Time, on Tuesday, May 12, 2026, or as soon thereafter as possible. Please notify Sean F. Reid of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 896-0610 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request. Very truly yours, BIOAFFINITY TECHNOLOGIES, INC. By: /s/ Maria Zannes Name: Maria Zannes Title: Chief Executive Officer